Poseida Therapeutics, Inc.

Cell Engineering and Gene Editing of T-cells, managed and worked with matrix teams in discovery and platform development, leading to IND submissions of multiple CAR-T programs targeting BCMA and MUC-1. Advanced the Healthy Donor Program, utilizing cell separation technologies, in-vitro/in-vivo characterization, and correlation/statistical analysis to support Poseida's Allogeneic programs.

ImmunityBio (formerly Nantkwest)

Development and optimization of NK-cell isolations from PBMC and Cord blood sources from small-scale to GMP-grade bioreactors. Demonstrated NK functional cytotoxicity to multiple target cell lines and safety profile to multiple PBMC healthy donors.

Intrexon Corp.

In the nanoparticle field, isolation of exosomes from Bovine milk/cell supernatant, optimizing a combination of exosome purification techniques (ultra-centrifugation, size-exclusion chromatography), verification of isolated exosomes, and high-throughput screening characterization of loaded exosomes in human fibroblasts to measure bioactivity.

Stem Cell Core Facility, UCSD

Human embryonic stem cell culture, provided stem cells to UCSD graduate students by manual/ enzymatic passaging to maintain pluripotent state. Daily operation, maintenance, and calibration of Flow cytometers and sorters, purifying experiment-specific cell subsets, ranging from human immune cells and neurons, to mouse and plants.